Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

NCT03287232 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

653

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoactive Sexual Desire Disorder

Interventions

DRUG: Placebo Vaginal Insert
DRUG: Prasterone 6.5 mg (0.50%) Vaginal Insert

Sponsor

EndoCeutics Inc.